Journal article icon

Journal article

25 years of biologic DMARDs in rheumatology

Abstract:

2023 marks 25 years since the approval of the first biologic drug in rheumatology. In this Viewpoint, five rheumatology researchers discuss how biologic therapy has transformed clinical practice, reflecting on their own experience, past and current challenges and what the future might hold for biologic drugs.

Publication status:
Published

Actions

Access Document

Publisher copy:
10.1038/s41584-023-01036-x

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Sub department:
Kennedy Institute for Rheumatology
Role:
Author


Publisher:
Springer Nature
Journal:
Nature Reviews Rheumatology More from this journal
Volume:
19
Issue:
12
Pages:
761-766
Publication date:
2023-11-02
Acceptance date:
2023-09-20
DOI:
EISSN:
1759-4804
ISSN:
1759-4790
Pmid:
37919339


Language:
English
Keywords:
Pubs id:
1562555
Local pid:
pubs:1562555
Deposit date:
2026-02-04
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP